Future pharma host, Romain Bonjean, CEO of RoseRx, sits down with AJ Rollsy, founder and Managing Director of HealthPoint Research, who brings 25 years of global pharma and sales experience. They explore how AI is reshaping patient and HCP engagement, the tension between innovation and governance, the emotional and behavioural drivers behind health decisions and what pharma can learn from other industries, using examples from GLP-1 weight management, DTC models and global market nuances. AJ...
All content for future pharma, brought to you by RoseRx is the property of RoseRx and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Future pharma host, Romain Bonjean, CEO of RoseRx, sits down with AJ Rollsy, founder and Managing Director of HealthPoint Research, who brings 25 years of global pharma and sales experience. They explore how AI is reshaping patient and HCP engagement, the tension between innovation and governance, the emotional and behavioural drivers behind health decisions and what pharma can learn from other industries, using examples from GLP-1 weight management, DTC models and global market nuances. AJ...
Future pharma host, Romain Bonjean, CEO of RoseRx, sits down with AJ Rollsy, founder and Managing Director of HealthPoint Research, who brings 25 years of global pharma and sales experience. They explore how AI is reshaping patient and HCP engagement, the tension between innovation and governance, the emotional and behavioural drivers behind health decisions and what pharma can learn from other industries, using examples from GLP-1 weight management, DTC models and global market nuances. AJ...
Future pharma host, Romain Bonjean, CEO of RoseRx, sits down with AJ Rollsy, founder and Managing Director of HealthPoint Research, who brings 25 years of global pharma and sales experience. They explore how AI is reshaping patient and HCP engagement, the tension between innovation and governance, the emotional and behavioural drivers behind health decisions and what pharma can learn from other industries, using examples from GLP-1 weight management, DTC models and global market nuances. AJ...
